RAMM Pharma CorpCanadian Securities Exchange:RAMM
- LAST PRICE0.0100
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0100/ 398
- Ask / Lots0.0150/ 46
- Open / Previous Close--- / 0.0100
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RAMM |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
RAMM Pharma Corp | 1.2M | -0.1x | --- |
StageZero Life Sciences Ltd | 4.9M | 0.0x | --- |
Waverley Pharma Inc | 810.0K | -0.4x | --- |
Entheon Biomedical Corp | 1.2M | -2.9x | --- |
HAVN Life Sciences Inc | 859.4K | 0.0x | --- |
Zenith Capital Corp | 789.4K | -1.3x | --- |
Company Information
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facility in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. Further it operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Glediser S.A., Canapar Corp, and Hempoland S.p.a Z.o.o.
Contact Information
- Headquarters
- 82 Richmond St. ETORONTO, ON, Canada M5C 1P1
- Phone
- 416-848-7744
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2M |
|---|---|
Revenue (TTM) | $4.5M |
Shares Outstanding | 119.4M |
RAMM Pharma Corp does not pay a dividend. | |
Beta | -0.20 |
EPS | $-0.07 |
Book Value | $0.25 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 0.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -176.65% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
